Arevalo-Martin A et al. |
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. |
2010 |
Neurobiol. Dis. |
pmid:20156559
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Panikashvili D et al. |
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. |
2006 |
Neurobiol. Dis. |
pmid:16364651
|
Vázquez C et al. |
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies. |
2015 |
Neurobiol. Dis. |
pmid:25917763
|
Avraham Y et al. |
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. |
2006 |
Neurobiol. Dis. |
pmid:16102970
|
Garcia-Ovejero D et al. |
The endocannabinoid system is modulated in response to spinal cord injury in rats. |
2009 |
Neurobiol. Dis. |
pmid:18930143
|
Fernández-Suárez D et al. |
Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. |
2014 |
Neurobiol. Aging |
pmid:24973119
|
Feliszek M et al. |
Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. |
2016 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:26984820
|
Schulte K et al. |
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. |
2012 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:22215206
|
Ameri A and Simmet T |
Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10731038
|
Ilayan E et al. |
Do cannabinoids exhibit a tyramine-like effect? |
2013 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:23900610
|
Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Di Marzo V et al. |
Trick or treat from food endocannabinoids? |
1998 |
Nature |
pmid:9872309
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Di Marzo V et al. |
Leptin-regulated endocannabinoids are involved in maintaining food intake. |
2001 |
Nature |
pmid:11298451
|
Wilson RI and Nicoll RA |
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. |
2001 |
Nature |
pmid:11279497
|
Stella N et al. |
A second endogenous cannabinoid that modulates long-term potentiation. |
1997 |
Nature |
pmid:9285589
|
Self DW |
Anandamide: a candidate neurotransmitter heads for the big leagues. |
1999 |
Nat. Neurosci. |
pmid:10204533
|
Di Marzo V |
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. |
2011 |
Nat. Neurosci. |
pmid:21187849
|